NCT05930262

Brief Summary

The goal of this prospective randomized controlled study is to explore the clinical efficacy of acupuncture therapy combined with breathing training in patients with stroke complicated with pulmonary infection. The intervention group and control group were treated with conventional drug therapy, rehabilitation therapy and breathing training for 2 consecutive weeks. On this basis, the intervention group additionally received acupuncture therapy. To evaluate the clinical efficacy of both groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started May 2020

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

June 6, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

July 5, 2023

Completed
Last Updated

July 5, 2023

Status Verified

June 1, 2023

Enrollment Period

1.1 years

First QC Date

June 6, 2023

Last Update Submit

June 25, 2023

Conditions

Keywords

Acupuncture therapyRespiratory trainingSeroinflammatory factorsLung function

Outcome Measures

Primary Outcomes (13)

  • Serum inflammatory factors:C-reactive protein (CRP) level

    C-reactive protein (CRP) level(mg/L)

    2 Weeks

  • Serum inflammatory factors:Calcitonin (PCT) level

    Calcitonin (PCT) level(ng/mL)

    2 Weeks

  • Serum inflammatory factors:WBC

    WBC (x 109/L)

    2 Weeks

  • Improvement time for symptoms and signs of pulmonary infection:Time of fever relieving

    the time for body temperature to return to normal (d)

    2 Weeks

  • Improvement time for symptoms and signs of pulmonary infection:Time for the disappearance of cough

    the time for the disappearance of cough (d)

    2 Weeks

  • Improvement time for symptoms and signs of pulmonary infection:Time for the disappearance of expectoration

    the time for the disappearance of expectoration (d)

    2 Weeks

  • Improvement time for symptoms and signs of pulmonary infection:Time for the disappearance of moist rales

    the time for the disappearance of moist rales (d)

    2 Weeks

  • TCM syndrome score

    Before and after treatment, TCM syndrome scores were counted in the two groups. The main and secondary symptoms were classified into 4 levels, with scores of 0, 1, 2 and 3 based on the severity of the symptoms. The tongue coating and pulse pattern were scored into 2 levels, with no scored as 0 and yes as 1. The sum of various scores was calculated as the total score, with a score range of 0-36. The higher the score, the severer the condition.

    2 Weeks

  • Clinical pulmonary infection score (CPIS)

    Before and after treatment, the 2 groups were scored comprehensively based on the average range of 12-h body temperature, WBC range, amount and character of tracheal secretions, index of gas exchange, pulmonary infiltration shadow of X-ray chest film, and pathogenic bacteria in sputum culture. According to the severity, they were divided into 3 levels, with a score of 0, 1 and 2. The maximum score was 12. The higher the score, the severer the infection.

    2 Weeks

  • Pulmonary indexes:forced vital capacity (FVC)

    To measure the forced vital capacity (FVC)(L) before and after treatment

    2 Weeks

  • Pulmonary indexes:forced expiratory volume in the first second (FEV1)

    To measure the forced expiratory volume in the first second (FEV1)(L/S) before and after treatment

    2 Weeks

  • Pulmonary indexes: peak expiratory flow (PEF)

    To measure the peak expiratory flow (PEF)(L/S) before and after treatment

    2 Weeks

  • Efficacy evaluation:Number of patients with clinical efficacy(Cured,Effective,Remarkably effective,Invalid)

    Efficacy was evaluated according to the Criteria of Diagnosis and Therapeutic Effect of Diseases and Symptoms in Traditional Chinese Medicine . Cured: Clinical adverse symptoms such as cough, expectoration and chest tightness disappeared, inflammation was absorbed on X-ray or CT, and routine blood indexes were normal. Remarkably effective: Adverse symptoms such as cough, expectoration and chest tightness were improved significantly, and X-ray or CT and routine blood test results basically returned to normal. Effective: Clinical adverse symptoms such as cough, expectoration and chest tightness were relieved, and X-ray or CT and routine blood test results were improved partially. Invalid: Clinical adverse symptoms such as cough, expectoration and chest tightness had no changes or aggravated.

    2 Weeks

Study Arms (2)

the intervention group

EXPERIMENTAL

TCM acupuncture therapy Conventional drug therapy Rehabilitation therapy Breathing training

Device: TCM acupuncture therapyDrug: Conventional drug therapyBehavioral: Rehabilitation therapyBehavioral: Breathing training

the control group

ACTIVE COMPARATOR

Conventional drug therapy Rehabilitation therapy Breathing training

Drug: Conventional drug therapyBehavioral: Rehabilitation therapyBehavioral: Breathing training

Interventions

TCM acupuncture therapy: Zusanli, Quchi, Hegu, Taichong, Feishu and Fenglong were selected as the main acupoints, and the auxiliary acupoints were selected according to the symptoms, including Fengchi, Dazhui, Lieque, Tiantu, Shenshu, Zhongfu, etc.

the intervention group

Antibiotics were selected based on drug sensitivity test results. Patients with body temperature \> 38.5℃ were treated with physical cooling and antipyretic drugs. In patients whose sputum was thick and difficult to cough up, nebulization and inhalation therapy was given, as well as effective coughing and patting the back to expel phlegm were guided.

the control groupthe intervention group

Comprehensive training for hemiplegic limbs included a joint range of motion training, bridging exercise, turnover training, balance training, gait training, hand function training and self-care ability training, 40 min/d, 6 times/w.

the control groupthe intervention group

Training was conducted daily in the morning, or after symptom relief in the case of fever or other discomforts, once a day, 30-40 min/time.

the control groupthe intervention group

Eligibility Criteria

Age28 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meeting the diagnostic criteria of Western medicine for stroke complicated with pneumonia
  • conforming to the TCM syndrome of vital qi deficiency and phlegm-heat obstructing the lung
  • confirmed as the initial onset of stroke through CT or magnetic resonance imaging (MRI)
  • clear consciousness, no cognitive impairment, and ability to cooperate with pulmonary function assessment and rehabilitation training
  • willingness to participate in this study and sign the informed consent

You may not qualify if:

  • Patients with systemic multi-organ failure such as the heart, brain, kidney, etc
  • patients with a coronary metal stent or pacemaker implantation
  • patients with malignant tumors
  • patients with severe cognitive impairment, depression or mental disorders
  • patients with pulmonary infections before stroke or caused by other causes
  • patients in the acute phase of infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Acupuncture Therapy Combined with Breathing Training for Patients with Stroke Complicated with Pulmonary Infection: A Clinical Study

Shijiazhuang, Hebei, 050000, China

Location

MeSH Terms

Conditions

StrokeLung Diseases

Interventions

RehabilitationBreathing Exercises

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesMind-Body TherapiesComplementary TherapiesExercise Movement TechniquesPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 6, 2023

First Posted

July 5, 2023

Study Start

May 1, 2020

Primary Completion

May 31, 2021

Study Completion

June 1, 2023

Last Updated

July 5, 2023

Record last verified: 2023-06

Locations